Document is current
Any future updates will be listed below
-
Authors
Bader, Ilse
Groot, Colin
Tan, H. Stevie
Milongo, Jean-Marie A.
Haan, Jurre den
Verberk, Inge M. W.
Yong, Keir
Orellina, Julie
Campbell, Shannon
Wilson, David
van Harten, Argonde C.
Kok, Pauline H. B.
van der Flier, Wiesje M.
Pijnenburg, Yolande A. L.
Barkhof, Frederik
van de Giessen, Elsmarieke
Teunissen, Charlotte E.
Bouwman, Femke H.
Ossenkoppele, Rik
- License Information
-
More Information
Article History
Received: 1 May 2024
Accepted: 25 July 2024
First Online: 21 August 2024
Declarations
:
: The BeyeOMARKER study (Eudamed CIV ID: CIV-NL-23–09-044086) and the BeyeOMARKER biobank were approved by the ethical review board of the VU Medical Center (VUmc). All of the participants will be asked to provide written informed consent to participate in the study.
: Not applicable.
: CT is editor-in-chief of Alzheimer Research and Therapy. RO is part of the editorial board of Alzheimer’s Research and Therapy.
